Command Palette

Search for a command to run...

asston-pharmaceuticals

98+0.00%
Market Cap
₹0.00 Cr
Stock P/E
0.00
ROCE
0.00%
ROE
0.00%
Book Value
₹0.00

You might have missed

No Recent News

No recent news available for this stock.

Shareholding

Holdings
Distribution
Promoter
Others

From Last Concall

No Concall Summary

Conference call summary is not available for this stock.

Peers Summary

Sector Leader

Asston Pharmaceuticals Ltd. shows no growth metrics and lacks profitability indicators like ROE, ROA, and EBITDA margins, positioning it as a laggard in the sector. In contrast, peers such as Sun Pharmaceutical and Dr. Reddy's Laboratories demonstrate strong growth, profitability, and efficient capital utilization, while others like Divi's Laboratories struggle with declining revenues.

Key Points
  • Asston Pharmaceuticals has zero revenue growth and no profitability metrics, indicating a lack of operational efficiency.
  • Sun Pharmaceutical and Dr. Reddy's Laboratories are sector leaders with high ROE, EPS, and growth metrics.
  • Divi's Laboratories shows concerning trends with negative revenue growth over three years.
Top Performers
Sun Pharmaceutical Industries Ltd.

Highest revenue growth YoY (8.42%) and 3-Year EPS growth (45.55).

Dr. Reddy's Laboratories Ltd.

Strong profitability with a ROE of 21.76% and solid revenue growth (16.54% YoY).

Leveling the playing field in markets.

© 2025 EQHQ Technologies Pvt Ltd

"Information provided is for educational purposes only and not financial advice.